BACKGROUND: In sub-Saharan Africa couple HIV testing and counseling (CHTC) has been associated with substantial increases in safe sex, especially when at least one partner is HIV infected. However, this relationship has not been characterized in an Option B+ context. SETTING: The study was conducted at the antenatal clinic at Bwaila District Hospital in Lilongwe, Malawi in 2016 under an Option B+ program. METHODS: Ninety heterosexual couples with an HIV-infected pregnant woman (female-positive couples) and 47 couples with an HIV-uninfected pregnant woman (female-negative couples) were enrolled in an observational study. Each couple member was assessed immediately before and 1 month after CHTC for safe sex (abstinence or consistent condom use in the last month). Generalized estimating equations were used to model change in safe sex before and after CHTC and to compare safe sex between female-positive and female-negative couples. RESULTS: Mean age was 26 years among women and 32 years among men. Before CHTC, safe sex was comparable among female-positive couples (8%) and female-negative couples (2%) [risk ratio (RR): 3.7, 95% confidence interval (CI): 0.5 to 29.8]. One month after CHTC, safe sex was higher among female-positive couples (75%) than among female-negative couples (3%) (RR: 30.0, 95% CI: 4.3 to 207.7). Safe sex increased substantially after CTHC for female-positive couples (RR 9.6, 95% CI: 4.6 to 20.0), but not for female-negative couples (RR: 1.2, 95% CI: 0.1 to 18.7). CONCLUSIONS: Engaging pregnant couples in CHTC can have prevention benefits for couples with an HIV-infected pregnant woman, but additional prevention approaches may be needed for couples with an HIV-uninfected pregnant woman.
BACKGROUND: In sub-Saharan Africa couple HIV testing and counseling (CHTC) has been associated with substantial increases in safe sex, especially when at least one partner is HIV infected. However, this relationship has not been characterized in an Option B+ context. SETTING: The study was conducted at the antenatal clinic at Bwaila District Hospital in Lilongwe, Malawi in 2016 under an Option B+ program. METHODS: Ninety heterosexual couples with an HIV-infected pregnant woman (female-positive couples) and 47 couples with an HIV-uninfected pregnant woman (female-negative couples) were enrolled in an observational study. Each couple member was assessed immediately before and 1 month after CHTC for safe sex (abstinence or consistent condom use in the last month). Generalized estimating equations were used to model change in safe sex before and after CHTC and to compare safe sex between female-positive and female-negative couples. RESULTS: Mean age was 26 years among women and 32 years among men. Before CHTC, safe sex was comparable among female-positive couples (8%) and female-negative couples (2%) [risk ratio (RR): 3.7, 95% confidence interval (CI): 0.5 to 29.8]. One month after CHTC, safe sex was higher among female-positive couples (75%) than among female-negative couples (3%) (RR: 30.0, 95% CI: 4.3 to 207.7). Safe sex increased substantially after CTHC for female-positive couples (RR 9.6, 95% CI: 4.6 to 20.0), but not for female-negative couples (RR: 1.2, 95% CI: 0.1 to 18.7). CONCLUSIONS: Engaging pregnant couples in CHTC can have prevention benefits for couples with an HIV-infected pregnant woman, but additional prevention approaches may be needed for couples with an HIV-uninfected pregnant woman.
Authors: Leigh F Johnson; Kathryn Stinson; Marie-Louise Newell; Ruth M Bland; Harry Moultrie; Mary-Ann Davies; Thomas M Rehle; Rob E Dorrington; Gayle G Sherman Journal: J Acquir Immune Defic Syndr Date: 2012-04-01 Impact factor: 3.731
Authors: Ron Gray; Victor Ssempiija; James Shelton; David Serwadda; Fred Nalugoda; Joseph Kagaayi; Godfrey Kigozi; Maria J Wawer Journal: AIDS Date: 2011-03-27 Impact factor: 4.177
Authors: Lyson Tenthani; Andreas D Haas; Matthias Egger; Joep J Van Oosterhout; Andreas Jahn; Frank Chimbwandira; Kali Tal; Landon Myer; Janne Estill; Olivia Keiser Journal: J Acquir Immune Defic Syndr Date: 2015-08-15 Impact factor: 3.731
Authors: Amy A Conroy; Kristi E Gamarel; Torsten B Neilands; John A Sauceda; Lynae A Darbes; Samantha E Dilworth; Jonelle M Taylor; Mallory O Johnson Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731
Authors: Andreas D Haas; Lyson Tenthani; Malango T Msukwa; Kali Tal; Andreas Jahn; Oliver J Gadabu; Adrian Spoerri; Frank Chimbwandira; Joep J van Oosterhout; Olivia Keiser Journal: Lancet HIV Date: 2016-03-09 Impact factor: 12.767
Authors: Nora E Rosenberg; Audrey E Pettifor; Guy De Bruyn; Daniel Westreich; Sinead Delany-Moretlwe; Frieda Behets; Suzanne Maman; David Coetzee; Mercy Kamupira; William C Miller Journal: J Acquir Immune Defic Syndr Date: 2013-02-01 Impact factor: 3.731
Authors: Austin Wesevich; Mina C Hosseinipour; Carol E Golin; Nuala McGrath; Mercy Tsidya; Limbikani Chimndozi; Nivedita Bhushan; Irving Hoffman; William C Miller; Nora E Rosenberg Journal: AIDS Care Date: 2019-06-25
Authors: Nora E Rosenberg; Lauren A Graybill; Austin Wesevich; Nuala McGrath; Carol E Golin; Suzanne Maman; Mercy Tsidya; Limbikani Chimndozi; Irving F Hoffman; Mina C Hosseinipour; William C Miller Journal: AIDS Behav Date: 2018-06
Authors: Nora E Rosenberg; Margaret W Gichane; Dhrutika Vansia; Twambilile Phanga; Nivedita L Bhushan; Linda-Gail Bekker; Audrey E Pettifor Journal: AIDS Behav Date: 2020-05
Authors: Nivedita L Bhushan; Marie C D Stoner; Allison K Groves; Kathleen Kahn; Audrey E Pettifor Journal: J Adolesc Health Date: 2022-03-31 Impact factor: 7.830
Authors: Nivedita L Bhushan; Carol E Golin; Nuala McGrath; Suzanne Maman; Mercy Tsidya; Limbikani Chimndozi; Austin Wesevich; Irving F Hoffman; Mina C Hosseinipour; William C Miller; Nora E Rosenberg Journal: AIDS Care Date: 2018-09-05
Authors: Zachary A Kwena; Stella W Njuguna; Ali Ssetala; Janet Seeley; Leslie Nielsen; Jan De Bont; Elizabeth A Bukusi Journal: PLoS One Date: 2019-03-25 Impact factor: 3.240
Authors: Katrina F Ortblad; Daniel K Musoke; Thomson Ngabirano; Joshua A Salomon; Jessica E Haberer; Margaret McConnell; Catherine E Oldenburg; Till Bärnighausen Journal: J Int AIDS Soc Date: 2019-07 Impact factor: 5.396